INO vs SHW · $88.0M cap vs P/E 29, rev $12.46B
Inovio Pharmaceuticals Inc (INO) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
INO currently screens at market cap $88.0M. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the INO and SHW stock pages for the full models.
Not investment advice.